Atlas Trials

HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer

Clinical trial NCT06217042 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06217042
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2024-02-05
Primary completion
2027-03-30
Enrollment
524

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.